ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 656925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 656925; 2) Community: the network communities that were significantly associated with the response to NSC 656925; 3) Molecule: the relationships between components within communities and NSC 656925; 4) MDR: the compounds that were significantly associated with the NSC 656925.

NSC Compound Enrichment Correlation
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0406225271888776 0.40293944
NSC 264880 Dihydro-5-azacytidine 0.0406225271888776 0.33672655
NSC 268993 Deferoxamine hydrochloride 0.0406225271888776 0.21662523
NSC 302991 Camptothecin Derivative 0.0406225271888776 0.22832708
NSC 328785 ANTINEOPLASTIC-328785 0.0406225271888776 0.24297128
NSC 343499 CI-921: amsacrine derivative 0.0406225271888776 0.32075913
NSC 361667 Null 0.0406225271888776 0.15635223
NSC 409304 Null 0.0406225271888776 0.1100372
NSC 605607 Null 0.0406225271888776 0.21233739
NSC 607088 Null 0.0406225271888776 0.044631948
Total:80  Current:65    [First] [Prev] [Next] [Last]